Your shopping cart is currently empty

PARP-2-IN-3 is used as a potent PARP-2 inhibitor (IC50=0.07 μM) with anti-tumor activity that induces apoptosis and necrosis in cancer cells, and can be used for the study of breast cancer.128-52-56-8

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $350 | - | In Stock | |
| 5 mg | $970 | - | In Stock | |
| 25 mg | $1,590 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock |
| Description | PARP-2-IN-3 is used as a potent PARP-2 inhibitor (IC50=0.07 μM) with anti-tumor activity that induces apoptosis and necrosis in cancer cells, and can be used for the study of breast cancer.128-52-56-8 |
| Targets&IC50 | PARP2:0.07 μM |
| In vitro | PARP-2-IN-3 (Compound 12) proved to be the most active PARP-2 inhibitor with an IC50 value of 0.07 µM, respectively.PARP-2-IN-3 induced cell cycle arrest at G2/M and G1/S phases in a mutant MCF-7 cell line, and possessed significant apoptosis-inducing activity[1]. |
| Molecular Weight | 385.84 |
| Formula | C20H20ClN3O3 |
| Cas No. | 2915650-86-9 |
| Smiles | O=C(NC=1C=CC(=CC1)C2=NC3=CC(Cl)=CC=C3O2)CCN4CCOCC4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.